$10.50
-0.01 (-0.05%)
Open$10.50
Previous Close$10.51
Day High$10.50
Day Low$10.50
52W High$10.59
52W Low$10.11
Volume—
Avg Volume254.5K
Market Cap393.95M
P/E Ratio42.08
EPS$0.48
SectorN/A
Analyst Ratings
Sell
9 analysts
Price Target
+216.7% upside
Current
$10.50
$10.50
Target
$33.25
$33.25
$21.69
$33.25 avg
$38.82
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 229.75M | 221.12M | 203.42M |
| Net Income | 18.67M | 19.49M | 13.94M |
| Profit Margin | 8.1% | 8.8% | 6.9% |
| EBITDA | 31.30M | 28.96M | 26.35M |
| Free Cash Flow | 15.11M | 9.40M | 12.42M |
| Rev Growth | +0.0% | -7.2% | +5.6% |
| Debt/Equity | 0.24 | 0.28 | 0.30 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $0.96 | -21.55% | — | 1.23B |
| PICS | Pics Nv | $6.96 | -3.06% | 3.7 | 888.97M |
| DMII | Drugs Made In America Acquis | $10.26 | +0.29% | 50.0 | 651.01M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.61 | +0.09% | 27.6 | 219.04M |
| CEPF | Cantor Equity Partners-Cl A | $10.35 | +0.00% | 41.5 | 589.79M |